Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's Lymphoma (SAPHIRE)
This study is ongoing, but not recruiting participants.
Sponsor:
4SC AG
Information provided by:
4SC AG
ClinicalTrials.gov Identifier:
NCT01037478
First received: December 22, 2009
Last updated: February 29, 2012
Last verified: February 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | March 2012 |
| Primary Completion Date: | January 2012 (Final data collection date for primary outcome measure) |